Is mapping a baby's genetic disease risk a healthcare miracle or a step too far?
The article discusses the implications of newborn genomic testing that reveals genetic disease risks, weighing its potential benefits against ethical concerns and psychological impacts.
Assisted reproduction: What applies to the screening for Spinal Muscular Atrophy in sperm from the European Sperm Bank
The National Authority for Medically Assisted Reproduction in Greece informs Assisted Reproduction Units and Cryopreservation Banks about the required genetic testing for Spinal Muscular Atrophy to ensure the quality and safety of assisted reproduction services.
Danish sperm donor: New 'warning' to Assisted Reproductive Units – The new risk, what to watch out for
Representatives of the National Authority have issued new recommendations to the leaders of Assisted Reproductive Units regarding Danish sperm donors after discovering that genetic screening for a serious condition was not mandatory in Denmark until three years ago.
LIFESAVING INNOVATION: Estonia to mass test for severe genetic disease
Starting in 2026, Estonia will offer cystic fibrosis screening to all children born in the country, enabling early treatment and prevention of organ damage.
Calls for SMA screening ignored before Jesy Nelson campaign, say families
Families claim their demands for spinal muscular atrophy (SMA) screening in newborns were overlooked until Jesy Nelson's campaign brought attention to the issue.